Earnings Call · Q3 FY2024·2024-11-06

Q3 24EPS -7.69%·Rev n/aQ2 24EPS -15.38%·Rev n/aQ1 24EPS +6.67%·Rev n/aQ4 23EPS 0.00%·Rev n/a⚠ consensus missing

Arbutus Biopharma Corp ABUS

Lisa Caperelli — Host / Investor Relations

Mike McElhaugh — Interim President and Chief Executive Officer

Dave Hastings — Chief Financial Officer

−1.0%1d on move date−3.5% vs SPY3d−5.3%5d−8.1%

Research tier

Behavioral profile computed for 3 speakers on this call.

Sign in to view the Behavioral Lean, the Behavioral Deviation Score, the speaker decomposition, and the novel forward-guidance phrases flagged on this call — each scored against the speaker's own prior-call baseline.

Behavioral data on every earnings call

Per-speaker language deviation, scored against each executive's own history. Explore more ABUS calls or request research access.

More ABUS calls Browse calls Request research access